Beneficial effects of a novel thyromimetic on lipoprotein metabolism
Pan-cancer analyses reveal that CHAC1 expression is highly variable, being upregulated in many cancers (e.g., breast, ovarian, lung, bladder carcinomas) and downregulated in others (e.g., certain head/neck, kidney, and brain cancers) (Li, D
Month 6: peak velocity has passed At the six-month mark, you have likely lost 12 to 15 percent of your starting body weight if you reached the full 2.4 mg dose on schedule and responded at or above the average rate
doi: 10.3389/fendo.2026.1762596 Received 07 December 2025 Revised 21 February 2026 Accepted 02 March 2026 Published 16 March 2026 Volume 17 - 2026 Edited by Claire Joanne Stocker, Aston University, United Kingdom Reviewed by Damasia Becu-Villalobos, CONICET Institute of Biology and Experimental Medicine (IBYME), Argentina Edward Wargent, University of Buckingham, United Kingdom Dzilda Velickiene, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Lithuania Updates Copyright 2026 Wang, Luo, Fang, Ge, Huang and Deng
